Published 1 year ago • loading... • Updated 1 year ago
Genetic medicine can leave people with rare mutations behind. But there's new hope
Patients with rare genetic mutations of cystic fibrosis have fewer treatment options than those with common mutations, as noted by researchers discussing mutation-agnostic gene therapies.
Kramer-Golinkoff is diagnosed with cystic fibrosis due to a rare mutation, which current treatments cannot address, affecting 40,000 Americans diagnosed with the disease overall.
Gene therapy trials at Columbia University aim to improve lung function and overall health, providing hope for patients with cystic fibrosis.
Despite worsening health, Kramer-Golinkoff expresses optimism about future therapies, noting that having trials underway provides hope for those with cystic fibrosis.